Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H28N2O5S |
Molecular Weight | 408.512 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=C(OCCN[C@H](C)CC2=CC(=C(OC)C=C2)S(N)(=O)=O)C=CC=C1
InChI
InChIKey=DRHKJLXJIQTDTD-OAHLLOKOSA-N
InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1
Molecular Formula | C20H28N2O5S |
Molecular Weight | 408.512 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:11:28 UTC 2023
by
admin
on
Fri Dec 15 16:11:28 UTC 2023
|
Record UNII |
G3P28OML5I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QG04CA52
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
||
|
WHO-ATC |
G04CA52
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
||
|
NDF-RT |
N0000175553
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
||
|
LIVERTOX |
NBK548017
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
||
|
NCI_THESAURUS |
C29713
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
||
|
WHO-VATC |
QG04CA02
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
||
|
NDF-RT |
N0000000099
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
||
|
WHO-VATC |
QG04CA53
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
||
|
WHO-ATC |
G04CA53
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
||
|
WHO-ATC |
G04CA02
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
106133-20-4
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
TAMSULOSIN
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
9398
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
77492
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | RxNorm | ||
|
m10451
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID3023631
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
G3P28OML5I
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
DB00706
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
2562
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
G3P28OML5I
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
129211
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
100000082422
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
488
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
6750
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
C088482
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
SUB10827MIG
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
CHEMBL836
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
C75055
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY | |||
|
7744
Created by
admin on Fri Dec 15 16:11:28 UTC 2023 , Edited by admin on Fri Dec 15 16:11:28 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Ki
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
TARGET -> INHIBITOR |
Ki
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
PLASMA
|
||
|
METABOLITE -> PARENT |
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
PLASMA
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
PLASMA
|
||
|
METABOLITE -> PARENT |
PLASMA
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||